According to a recent LinkedIn post from Zeto Inc, the company plans to participate in the American Clinical Neurophysiology Society Annual Meeting in New Orleans from February 19–22, 2026. The post indicates Zeto will be involved in the event’s inaugural Innovative Technology Lab, which is focused on point-of-care EEG technologies.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The company’s LinkedIn post highlights that CEO Florian Strelzyk is expected to present Zeto ONE, described as a full-montage EEG solution aimed at advancing EEG use in critical care and other clinical settings. For investors, this exposure at a specialized neurophysiology conference may support brand visibility among clinicians and hospital decision-makers, potentially aiding long-term adoption and positioning Zeto within the evolving point-of-care EEG market.